|
SLU7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.060120E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.559940E-03 |
| Normal-vs-Stage2 |
3.009800E-01 |
| Normal-vs-Stage3 |
3.750400E-01 |
| Normal-vs-Stage4 |
9.178600E-01 |
| Stage1-vs-Stage2 |
5.654000E-01 |
| Stage1-vs-Stage3 |
3.548200E-01 |
| Stage1-vs-Stage4 |
3.281800E-01 |
| Stage2-vs-Stage3 |
8.323000E-01 |
| Stage2-vs-Stage4 |
6.139000E-01 |
| Stage3-vs-Stage4 |
7.091200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.950300E-04 |
| Normal-vs-AfricanAmerican |
5.373600E-02 |
| Normal-vs-Asian |
7.501200E-01 |
| Caucasian-vs-AfricanAmerican |
6.082000E-01 |
| Caucasian-vs-Asian |
6.017800E-01 |
| AfricanAmerican-vs-Asian |
7.101400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.82070000000123E-05 |
| Normal-vs-Female |
8.933200E-01 |
| Male-vs-Female |
3.337000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.650100E-02 |
| Normal-vs-Extreme_Weight |
3.55400000000561E-05 |
| Normal-vs-Obese |
3.575800E-01 |
| Normal-vs-Extreme_Obese |
1.397720E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.587200E-01 |
| Normal_Weight-vs-Obese |
3.753200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.782200E-01 |
| Extreme_Weight-vs-Obese |
2.179900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.029200E-01 |
| Obese-vs-Extreme_Obese |
1.343570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.438000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.062600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.86190000000175E-05 |
| Normal-vs-Age(81-100Yrs) |
6.238100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.954600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.731000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.267800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.292090E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.951800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.847800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.31029999999888E-05 |
| Normal-VS-Type2 PRCC |
2.941800E-01 |
| Normal-VS-KIRP CIMP |
3.687800E-01 |
| Normal-VS-Unclassified PRCC |
5.564000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.304300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.575600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.318100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.030400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.674200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.227800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.744150E-03 |
| Normal-vs-N1 |
5.914400E-01 |
| Normal-vs-N2 |
6.814400E-02 |
| N0-vs-N1 |
1.224410E-02 |
| N0-vs-N2 |
9.294200E-01 |
| N1-vs-N2 |
2.932000E-01 |
|
|
